SBI Mutual Fund acquired a 0.54% stake (6.41 lakh shares) in Alkem Laboratories for ₹300 crore at ₹4,680 per share, increasing its holding to 2.7% from 2.16%. The transaction, executed via an open market deal, saw shares offloaded by the Samprada & Nanhamati Singh Family Trust. This move signals strong institutional interest in the pharma sector amid ongoing market volatility.
